What is the latest news on structured interrupted treatment? Should a healthy HIV positive person consider an STI? What are the risks involved and for how long should the meds be interrupted? Is there any chance of developing resistance?

J. E. Gallant

Research output: Chapter in Book/Report/Conference proceedingChapter

Fingerprint Dive into the research topics of 'What is the latest news on structured interrupted treatment? Should a healthy HIV positive person consider an STI? What are the risks involved and for how long should the meds be interrupted? Is there any chance of developing resistance?'. Together they form a unique fingerprint.